Search Results - "Rothstein, Jeffrey D."

Refine Results
  1. 1

    Current hypotheses for the underlying biology of amyotrophic lateral sclerosis by Rothstein, Jeffrey D.

    Published in Annals of neurology (01-01-2009)
    “…The mechanisms involved in selective motor neuron degeneration in amyotrophic lateral sclerosis remain unknown more than 135 years after the disease was first…”
    Get full text
    Journal Article
  2. 2

    Astrocyte Diversity: Current Insights and Future Directions by Westergard, Thomas, Rothstein, Jeffrey D.

    Published in Neurochemical research (01-06-2020)
    “…Astrocytes make up 20–40% of glial cells within the central nervous system (CNS) and provide several crucial functions, ranging from metabolic and structural…”
    Get full text
    Journal Article
  3. 3

    The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease by Haeusler, Aaron R., Donnelly, Christopher J., Rothstein, Jeffrey D.

    Published in Nature reviews. Neuroscience (01-06-2016)
    “…Key Points Since its discovery as the most common genetic abnormality in familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD),…”
    Get full text
    Journal Article
  4. 4

    Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies by Vucic, Steve, Rothstein, Jeffrey D, Kiernan, Matthew C

    Published in Trends in neurosciences (Regular ed.) (01-08-2014)
    “…Highlights • The pathophysiological mechanisms underlying amyotrophic lateral sclerosis (ALS) are multifactorial. • Genetic factors and dysfunction of vital…”
    Get full text
    Journal Article
  5. 5

    NG2 + CNS Glial Progenitors Remain Committed to the Oligodendrocyte Lineage in Postnatal Life and following Neurodegeneration by Kang, Shin H., Fukaya, Masahiro, Yang, Jason K., Rothstein, Jeffrey D., Bergles, Dwight E.

    Published in Neuron (Cambridge, Mass.) (18-11-2010)
    “…The mammalian CNS contains a ubiquitous population of glial progenitors known as NG2 + cells that have the ability to develop into oligodendrocytes and undergo…”
    Get full text
    Journal Article
  6. 6

    Rodent Models of Amyotrophic Lateral Sclerosis by Philips, Thomas, Rothstein, Jeffrey D

    Published in Current protocols in pharmacology (01-06-2015)
    “…Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease affecting upper and lower motor neurons in the central nervous system. Patients with ALS develop…”
    Get more information
    Journal Article
  7. 7

    Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis by Kang, Shin H, Li, Ying, Fukaya, Masahiro, Lorenzini, Ileana, Cleveland, Don W, Ostrow, Lyle W, Rothstein, Jeffrey D, Bergles, Dwight E

    Published in Nature neuroscience (01-05-2013)
    “…Oligodendrocytes form myelin sheaths and provide metabolic support to axons. Using in vivo genetic fate tracing in a mouse model of amyotrophic lateral…”
    Get full text
    Journal Article
  8. 8
  9. 9

    C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import by Hayes, Lindsey R, Duan, Lauren, Bowen, Kelly, Kalab, Petr, Rothstein, Jeffrey D

    Published in eLife (02-03-2020)
    “…Disruption of nucleocytoplasmic transport is increasingly implicated in the pathogenesis of neurodegenerative diseases, including ALS caused by a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS by Coyne, Alyssa N, Baskerville, Victoria, Zaepfel, Benjamin L, Dickson, Dennis W, Rigo, Frank, Bennett, Frank, Lusk, C Patrick, Rothstein, Jeffrey D

    Published in Science translational medicine (28-07-2021)
    “…Alterations in the components [nucleoporins (Nups)] and function of the nuclear pore complex (NPC) have been implicated as contributors to the pathogenesis of…”
    Get more information
    Journal Article
  12. 12
  13. 13

    G4C2 Repeat RNA Initiates a POM121-Mediated Reduction in Specific Nucleoporins in C9orf72 ALS/FTD by Coyne, Alyssa N., Zaepfel, Benjamin L., Hayes, Lindsey, Fitchman, Boris, Salzberg, Yuval, Luo, En-Ching, Bowen, Kelly, Trost, Hannah, Aigner, Stefan, Rigo, Frank, Yeo, Gene W., Harel, Amnon, Svendsen, Clive N., Sareen, Dhruv, Rothstein, Jeffrey D.

    Published in Neuron (Cambridge, Mass.) (23-09-2020)
    “…Through mechanisms that remain poorly defined, defects in nucleocytoplasmic transport and accumulations of specific nuclear-pore-complex-associated proteins…”
    Get full text
    Journal Article
  14. 14
  15. 15

    MCT1 Deletion in Oligodendrocyte Lineage Cells Causes Late-Onset Hypomyelination and Axonal Degeneration by Philips, Thomas, Mironova, Yevgeniya A., Jouroukhin, Yan, Chew, Jeannie, Vidensky, Svetlana, Farah, Mohamed H., Pletnikov, Mikhail V., Bergles, Dwight E., Morrison, Brett M., Rothstein, Jeffrey D.

    Published in Cell reports (Cambridge) (12-01-2021)
    “…Oligodendrocytes (OLs) are important for myelination and shuttling energy metabolites lactate and pyruvate toward axons through their expression of…”
    Get full text
    Journal Article
  16. 16

    A Helicase Unwinds Hexanucleotide Repeat RNA G‑Quadruplexes and Facilitates Repeat-Associated Non-AUG Translation by Liu, Honghe, Lu, Yu-Ning, Paul, Tapas, Periz, Goran, Banco, Michael T, Ferré-D’Amaré, Adrian R, Rothstein, Jeffrey D, Hayes, Lindsey R, Myong, Sua, Wang, Jiou

    Published in Journal of the American Chemical Society (19-05-2021)
    “…The expansion of a hexanucleotide repeat GGGGCC (G4C2) in the C9orf72 gene is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal…”
    Get full text
    Journal Article
  17. 17

    Nuclear pore dysfunction and disease: a complex opportunity by Fare, Charlotte M, Rothstein, Jeffrey D

    Published in Nucleus (Austin, Tex.) (01-12-2024)
    “…The separation of genetic material from bulk cytoplasm has enabled the evolution of increasingly complex organisms, allowing for the development of…”
    Get full text
    Journal Article
  18. 18

    The blood-brain barrier: an engineering perspective by Wong, Andrew D, Ye, Mao, Levy, Amanda F, Rothstein, Jeffrey D, Bergles, Dwight E, Searson, Peter C

    Published in Frontiers in neuroengineering (30-08-2013)
    “…It has been more than 100 years since Paul Ehrlich reported that various water-soluble dyes injected into the circulation did not enter the brain. Since…”
    Get full text
    Journal Article
  19. 19

    Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice by Yang, Yongjie, Vidensky, Svetlana, Jin, Lin, Jie, Chunfa, Lorenzini, Ileana, Frankl, Miriam, Rothstein, Jeffrey D.

    Published in Glia (01-02-2011)
    “…Astrocyte heterogeneity remains largely unknown in the CNS due to lack of specific astroglial markers. In this study, molecular identity of in vivo astrocytes…”
    Get full text
    Journal Article
  20. 20

    Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice by Mordes, Daniel A., Morrison, Brett M., Ament, Xanthe H., Cantrell, Christopher, Mok, Joanie, Eggan, Pierce, Xue, Carolyn, Wang, Jin-Yuan, Eggan, Kevin, Rothstein, Jeffrey D.

    Published in Neuron (Cambridge, Mass.) (25-11-2020)
    “…A hexanucleotide repeat expansion at C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD). Initial…”
    Get full text
    Journal Article